Skip to main content

Diagnostic Nanotools

Diagnostic Nanotools develops new diagnostic tools. In 2023, we worked in the context of projects DTS20/00093 and LCF/TR/CC21/52490005 Consolidate, funded by ISCIII and La Caixa, to develop a synthetic reagent to replace erythrocytes in classical haemagglutination assays used worldwide to track flu epidemics. This product detects several influenza virus types and can be mass produced for global distribution. Besides, we worked in the context of project AC21_2/00021 QUPID EuroNanoMed to produce point-of-care diagnostic devices for fast, simple and quantitative detection of malaria. Among others, we showed that assay automation using paper devices provides efficient biomarker detection with little user intervention. Finally, in project PID2020-118904RB-C22 RETOS, in collaboration with researchers at the National Centre of Microelectronics, we are developing a device for digital ultrasensitive detection of respiratory infections.

eCORE

  • Global Health
  • Personalized Medicine, Innovative Diagnostics, Molecular Imaging & Digital Health

Team

Group Leader
Eva Baldrich Rubio

Researchers
Briza Pérez López, Haridian Tato Mateo, Xana García Fernández

PhD Students
Judit Prat Trunas

Lab Technicians
Maria Urpí Castany

Publications

1
Publications
100.0
%Q1
12.60
Impact Factor
12.60
Average Impact Factor

Projects

Compact Analytical Tool for robust MALaria decentralized diagnosis and community surveillance (CATMAL; LCF/PR/HR23/52430013)
Principal Investigator: Eva Baldrich
Agency: La Caixa Foundation, CaixaResearch Health 2023
Funding: 989,940.75 € (346,550 € for VHIR)
Period: 2023-2026

Synthetic Erythrocytes for the Surveillance of Infectious Diseases (LCF/TR/CC21/52490005).
Principal Investigator: Eva Baldrich
Agency: La Caixa Foundation, Proyectos Consolidate
Funding: 238,920 €
Period: 2022-2024

Quantitative and storage-stable point-of-care diagnostic device (QUPID; AC21_2/00021)
Principal Investigator: Eva Baldrich
Agency: Instituto de Salud Carlos III - Unión Europea (FEDER/FSE) (EC/EURONANOMED-JTC/2021)
Funding: 214,333.35 €
Period: 2022-2024

Desarrollo de tests rápidos y ultrasensibles para infecciones respiratorias (PID2020-118904RB-C22)
Principal Investigator: Eva Baldrich
Agency: Ministerio de Ciencia e Innovación – Convocatoria Proyectos de I+D+i Orientada a los Retos de la Sociedad
Funding: 73,810 €
Period: 2021-2024

Dispositivo diagnóstico sintético como sustituto de los eritrocitos animales en los ensayos de hemaglutinación clásicos: aplicación a la vigilancia de los virus de la gripe (DTS20/00093)
Principal Investigator: Eva Baldrich
Agency: Instituto de Salud Carlos III – Convocatoria de Proyectos de Desarrollo Tecnológico en Salud
Funding: 104,500 €
Period: 2021-2023

Patents

Reagents and fast methods for pathogen characterization and serology testing
Priority Number: PCT/EP2020/066292
Priority Date: 12/06/2020
Applicants: VHIR

VHIR Annual Report 2023